Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

naftazone

Known as: 1,2-naphthoquinone-2-semicarbazone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
In the present study substituted 1,2-naphthoquinones were synthesized, purified and characterized by spectroscopic studies (UV… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2012
2012
To explore for the first time the tolerability and efficacy of naftazone in patients with Parkinson’s disease (PD). Proof‐of… Expand
1998
1998
It has been demonstrated that hyperproduction of nitric oxide (NO) plays a major role in the vasodilatation of cirrhosis; thus… Expand
1997
1997
Objective: To evaluate the effectiveness and best time course of prescription of 30 mg/day oral naftazone (N) in women with… Expand
  • table 1
  • table 2
  • table 3
  • table 4
1996
1996
Because of the considerable interest in the role of platelets and antiplatelet therapy in cardiovascular disease, including the… Expand
1995
1995
In the present study, the potential involvement of lipid peroxidation and disruption of lysosomal integrity in the pathogenesis… Expand
1995
1995
Reduction and glucuronidation of the vasoprotectant drug, naftazone, by human and rat liver microsomes and by recombinant UDP… Expand
1994
1994
Abstract— The preparation of hydrophilic matrix tablets able to release naftazone, a water‐insoluble drug, into an aqueous medium… Expand
1982
1982
The use of 1,2-naphthoquinone-2-semicarbazone, 1,2-naphthoquinone-2-semicarbzone-4-sulphonic acid and 1,2-naphthoquinone-2… Expand